devices that integrate glp-1 schedules and glucose data GLP-1-directed NMDA receptor antagonism for obesity treatment Optimizing GLP-1 Therapy Through Remote

screening and management around substance use disorders, eating disorders, mental health, and sleep

Repurposed by Pleiogenix with 4 NIH grants, led to a first-in-class, non-steroid drug for Alcoholic Hepatitis, a $3.B+ mkt without any approved FDA drugs

Tacke F, Randolph GJ

AFFF Firefighting Foam lawsuits aim to hold manufacturers accountable for putting peoples health at risk

The investment will focus on: Building oral solid-dose manufacturing capacity Establishing localized supply systems Supporting the production and supply of Orforglipron This project represents one of the largest global manufacturing expansion initiatives in Lillys history

A variety of unimolecular GLP-1R/GcgR dual agonists were built using the glucagon amino acid sequence as a template